UCLA Vine Street Clinic

The UCLA Vine Street Clinic (UVSC) was established in 2005 in order to study the diffusion of HIV among methamphetamine user networks. Since that time, it has served as a site for clinical trials, behavioral research, and direct services focusing on the treatment of addiction, HIV prevention, and the intersection of the two. It is unique in its location, bringing the best in academia from UCLA into a transitional neighborhood of predominately working poor, an area designated as a medically underserved. The facility includes exam and counseling rooms for patient care, a lab for collection and storage of biological samples, and group meeting space. Current services available at the clinic are detailed below. For more information or to schedule an appointment, call us at (866) 449-UCLA or email us at uclavsc@mednet.ucla.edu.

Our Current Programs Include:


Following up on the Phase I safety trial, the objective of this study is to test the safety and potential efficacy of ibudilast to treat methamphetamine dependence. The safety and tolerability of ibudilast for the treatment of methamphetamine was tested and pilot data on the medication’s effectiveness was promising. This outpatient study for treatment seeking, methamphetamine-dependent persons is currently being conducted at the UCLA Vine Street Clinic in Hollywood.



The goal of this project is to assemble a cohort of minority men who have sex with men (MMSM) who actively use substances and engage transmission risks. This will facilitate studies on interactions between substance use and HIV progression and/or transmission. This important cohort of MMSM will characterize: (i) effects substance use on risk behaviors, and network dynamics in exposed and infected MMSM on acquisition of HIV and other sexually transmitted infections (STIs: gonorrhea, Chlamydia, syphilis, Hepatitis C (HCV)); and (ii) the extent to which substance use in MMSM facilitates behaviors that transmit HIV compared to non-drug using MMSM.


HPTN 085: Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection (AMP)

This study will evaluate the safety, tolerability, and efficacy of the VRC01 antibody in preventing HIV-1 infection in healthy adults at high risk of HIV infection. This is also known as the AMP study (Antibody Mediated Prevention). Participants will be men who have sex with men (MSM) and transgender individuals. They will receive an IV infusion of the antibody or a placebo every 8 weeks for approximately two years. Additional study visits will be required in between infusions. All study visits will include blood collection and HIV testing and counseling.

17 la prep stories qtr flyer_Page_1

The LA PrEP Stories Project

The goal of the LA PrEP Stories Project is to learn about the experiences of Black and Latino men who have sex with men (BLMSM) who ARE and who ARE NOT using Pre-Exposure Prophylaxis (PrEP) for HIV prevention. With this information, we plan to create programs to help improve the experiences of people who may choose to use PrEP in the future. For more information, visit https://www.facebook.com/pg/LAPrEPStories/about/


According to a 1992 study published in the Journal of Sexually Transmitted Diseases, using a condom makes sex 10,000 times safer than not using a condom. The UCLA Vine Street Clinic has partnered with LA County to provide free condoms to the public. For more information, visit http://lacondom.com/find-free-condoms/


Find HIV/AIDS Prevention & Service Providers

Enter your address, city and state, or ZIP Code:

For more information on this widget, please visit AIDS.gov.

Widget by AIDS.gov.